Biotech Values

[flatlander_60048]

I agree that the information in the Barrons article was readily available. However, Barron's seems to play to an older demographic which like their information packaged neatly. A bigger question is whether the hiring of Symonds (a former Goldman Sacs exec)as CFO signals a change in NVS where they will try to increase visibility. Wed should be interesting.

FL